A comparative study of tissue distribution and excretion among three substances implicated in eosinophilia-myalgia syndrome.
Adachi
J
J
Department of Legal Medicine, Kobe University School of Medicine, Japan.
Ueno
Y
Y
Tatsuno
Y
Y
Gomez
M
M
Smith
C C
CC
Sternberg
E M
EM
D000409:Alanine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D000818:Animals; D001711:Biotransformation; D001921:Brain / Q000378:metabolism; D002243:Carbolines / Q000493:pharmacokinetics*; D016603:Eosinophilia-Myalgia Syndrome / Q000139:chemically induced*; D006801:Humans; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D051381:Rats; D014018:Tissue Distribution; D014364:Tryptophan / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
D002243:Carbolines; C070372:1,1'-ethylidene bis(tryptophan); C078798:3-(phenylamino)alanine; C038114:1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid; D014364:Tryptophan; D000409:Alanine